Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe ...

Pericarditis recurrence in lupus is more likely — and has a dose-dependent relationship — with oral prednisone treatment, ...

A common form of lupus is systemic lupus erythematosus. Systemic lupus erythematosus affects the whole body and can attack virtually any part of it, including skin, major organs, hair, muscles ...

Merck tested its oral TLR7/8 inhibitor enpatoran in two forms of lupus. The company reported positive phase 2 data from the cohort of cutaneous lupus erythematosus (CLE) patients late last year.

A new study sought to identify the frequency and determinants of flares for with people with systemic lupus erythematosus (SLE) with persistently active disease (PAD). Researchers found that both ...

CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus. N Engl J Med 2021;385:567-569. [2] Mackensen A. et al., Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus; ...

Urticarial vasculitis (UV) is a small vessel vasculitis presenting with urticarial-type lesions instead of ... with a 6-year history of systemic lupus erythematosus (SLE) and antiphospholipid ...

The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, P. R. China ...

Research projects that will improve outcomes for patients with systemic lupus erythematosus, develop long-acting therapies to treat hypertension and organ injury, and create pathways to vision for ...